Chemokines and chemokine receptors during COVID-19 infection BA Khalil, NM Elemam, AA Maghazachi Computational and structural biotechnology journal 19, 976-988, 2021 | 185 | 2021 |
Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis NM Elemam, S Hannawi, AA Maghazachi Immunotargets and therapy 2020 (9), 43—56, 2020 | 99 | 2020 |
Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk MY Hachim, BA Khalil, NM Elemam, AA Maghazachi Journal of Leucocyte Biology 108 (1), 323-338, 2020 | 62 | 2020 |
Innate lymphoid cells (ILCs) as mediators of inflammation, release of cytokines and lytic molecules NM Elemam, S Hannawi, AA Maghazachi Toxins 9 (12), 398, 2017 | 55 | 2017 |
Targeting chemokines and chemokine receptors in multiple sclerosis and experimental autoimmune encephalomyelitis S Dhaiban, M Al-Ani, NM Elemam, AA Maghazachi Journal of inflammation research, 619-633, 2020 | 44 | 2020 |
Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates NM Elemam, H Hannawi, I Al Salmi, KB Naeem, F Alokaily, S Hannawi Saudi medical journal 42 (2), 170, 2021 | 38 | 2021 |
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 35 | 2024 |
Understanding the role of innate immune cells and identifying genes in breast cancer microenvironment I Shihab, BA Khalil, NM Elemam, IY Hachim, MY Hachim, RA Hamoudi, ... Cancers 12 (8), 2226, 2020 | 33 | 2020 |
Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 Cells JS Muhammad, MN Jayakumar, NM Elemam, T Venkatachalam, TK Raju, ... ImmunoTargets and Therapy 8, 29, 2019 | 33 | 2019 |
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 32 | 2024 |
Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models RY Mekky, N El-Ekiaby, SA El Sobky, NM Elemam, RA Youness, ... Archives of Virology, 2019 | 32 | 2019 |
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 31 | 2024 |
Role of peripheral immune cells in multiple sclerosis and experimental autoimmune encephalomyelitis S Dhaiban, M Al-Ani, NM Elemam, MH Al-Aawad, Z Al-Rawi, ... Sci 3 (1), 12, 2021 | 30 | 2021 |
CXCL10 chemokine: a critical player in RNA and DNA viral infections NM Elemam, IM Talaat, AA Maghazachi Viruses 14 (11), 2445, 2022 | 29 | 2022 |
Complement system: an immunotherapy target in colorectal cancer IM Talaat, NM Elemam, M Saber-Ayad Frontiers in Immunology 13, 810993, 2022 | 26 | 2022 |
Clinical and laboratory profile of hospitalized symptomatic COVID-19 patients: case series study from the first COVID-19 center in the UAE S Hannawi, H Hannawi, KB Naeem, NM Elemam, MY Hachim, IY Hachim, ... Frontiers in cellular and infection microbiology 11, 632965, 2021 | 24 | 2021 |
Drugs for multiple sclerosis activate natural killer cells: do they protect against COVID-19 infection? M Al-Ani, NM Elemam, JE Hundt, AA Maghazachi Infection and Drug Resistance, 3243-3254, 2020 | 24 | 2020 |
Circulating soluble ACE2 and upstream microRNA expressions in serum of type 2 diabetes mellitus patients NM Elemam, H Hasswan, H Aljaibeji, N Sulaiman International journal of molecular sciences 22 (10), 5263, 2021 | 23 | 2021 |
The beneficial and debilitating effects of environmental and microbial toxins, drugs, organic solvents and heavy metals on the onset and progression of multiple sclerosis MY Hachim, NM Elemam, AA Maghazachi Toxins 11 (3), 147, 2019 | 23 | 2019 |
Mir-194 is a hepatocyte gate keeper hindering HCV entry through targeting CD81 receptor RY Mekky, NM El-Ekiaby, MT Hamza, NM Elemam, G Esmat, AI Abdelaziz Journal of Infection 70 (1), 78-87, 2015 | 23 | 2015 |